Home LiteratureArticle Details
PMID: 20849959 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

False positives in neuroimaging genetics using voxel-based morphometry data.

NeuroImage ·Vol. 54 ·No. 2 ·2011-01-15 ·Pages 992-1000

Silver M, Montana G, Nichols TE, Alzheimer's Disease Neuroimaging Initiative

Abstract

Voxel-wise statistical inference is commonly used to identify significant experimental effects or group differences in both functional and structural studies of the living brain. Tests based on the size of spatially extended clusters of contiguous suprathreshold voxels are also widely used due to their typically increased statistical power. In "imaging genetics", such tests are used to identify regions of the brain that are associated with genetic variation. However, concerns have been raised about the adequate control of rejection rates in studies of this type. A previous study tested the effect of a set of 'null' SNPs on brain structure and function, and found that false positive rates were well-controlled. However, no similar analysis of false positive rates in an imaging genetic study using cluster size inference has yet been undertaken. We measured false positive rates in an investigation of the effect of 700 pre-selected null SNPs on grey matter volume using voxel-based morphometry (VBM). As VBM data exhibit spatially-varying smoothness, we used both non-stationary and stationary cluster size tests in our analysis. Image and genotype data on 181 subjects with mild cognitive impairment were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI). At a nominal significance level of 5%, false positive rates were found to be well-controlled (3.9-5.6%), using a relatively high cluster-forming threshold, α(c)=0.001, on images smoothed with a 12 mm Gaussian kernel. Tests were however anticonservative at lower cluster-forming thresholds (α(c)=0.01, 0.05), and for images smoothed using a 6mm Gaussian kernel. Here false positive rates ranged from 9.8 to 67.6%. In a further analysis, false positive rates using simulated data were observed to be well-controlled across a wide range of conditions. While motivated by imaging genetics, our findings apply to any VBM study, and suggest that parametric cluster size inference should only be used with high cluster-forming thresholds and smoothness. We would advocate the use of nonparametric methods in other cases.

MeSH Terms
Brain/pathology,physiopathology Cognition Disorders/genetics,pathology False Positive Reactions Genotype Humans Magnetic Resonance Imaging Polymorphism, Single Nucleotide
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Silver Matt
Department of Mathematics, Imperial College London, London, UK.
Montana Giovanni
Nichols Thomas E
Alzheimer's Disease Neuroimaging Initiative
References (33)
33 references, click to expand
  1. Neuroimaging-genetic paradigms: a new approach to investigate the pathophysiology and treatment of cognitive deficits in schizophrenia.
    Harv Rev Psychiatry. 2006 Mar-Apr;14(2):78-91 PMID: 16603474
  2. Empirical comparison of maximal voxel and non-isotropic adjusted cluster extent results in a voxel-based morphometry study of comorbid learning disability with schizophrenia.
    Neuroimage. 2005 Nov 15;28(3):544-52 PMID: 16085427
  3. A genome-wide association study of schizophrenia using brain activation as a quantitative phenotype.
    Schizophr Bull. 2009 Jan;35(1):96-108 PMID: 19023125
  4. Voxel-based morphometry--the methods.
    Neuroimage. 2000 Jun;11(6 Pt 1):805-21 PMID: 10860804
  5. Detecting changes in nonisotropic images.
    Hum Brain Mapp. 1999;8(2-3):98-101 PMID: 10524599
  6. Anomalous neural circuit function in schizophrenia during a virtual Morris water task.
    Neuroimage. 2010 Feb 15;49(4):3373-84 PMID: 19948225
  7. Neuroimaging endophenotypes: strategies for finding genes influencing brain structure and function.
    Hum Brain Mapp. 2007 Jun;28(6):488-501 PMID: 17440953
  8. Global and local morphometric differences in recently abstinent methamphetamine-dependent individuals.
    Neuroimage. 2010 May 1;50(4):1392-401 PMID: 20096794
  9. Detecting activations in PET and fMRI: levels of inference and power.
    Neuroimage. 1996 Dec;4(3 Pt 1):223-35 PMID: 9345513
  10. Neuroanatomical correlates of cognitive self-appraisal in neurodegenerative disease.
    Neuroimage. 2010 Feb 15;49(4):3358-64 PMID: 19961939
  11. Controlling the familywise error rate in functional neuroimaging: a comparative review.
    Stat Methods Med Res. 2003 Oct;12(5):419-46 PMID: 14599004
  12. Correlation-based multivariate analysis of genetic influence on brain volume.
    Neurosci Lett. 2009 Feb 6;450(3):281-6 PMID: 19028548
  13. Gene discovery through imaging genetics: identification of two novel genes associated with schizophrenia.
    Mol Psychiatry. 2009 Apr;14(4):416-28 PMID: 19065146
  14. Can voxel based morphometry, manual segmentation and automated segmentation equally detect hippocampal volume differences in acute depression?
    Neuroimage. 2009 Mar 1;45(1):29-37 PMID: 19071222
  15. Intermediate phenotypes and genetic mechanisms of psychiatric disorders.
    Nat Rev Neurosci. 2006 Oct;7(10):818-27 PMID: 16988657
  16. Searching scale space for activation in PET images.
    Hum Brain Mapp. 1996;4(1):74-90 PMID: 20408187
  17. A common MECP2 haplotype associates with reduced cortical surface area in humans in two independent populations.
    Proc Natl Acad Sci U S A. 2009 Sep 8;106(36):15483-8 PMID: 19717458
  18. The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods.
    J Magn Reson Imaging. 2008 Apr;27(4):685-91 PMID: 18302232
  19. Investigating association of brain volumes with intracranial capacity in schizophrenia.
    Neuroimage. 2010 Feb 1;49(3):2503-8 PMID: 19770046
  20. Validating cluster size inference: random field and permutation methods.
    Neuroimage. 2003 Dec;20(4):2343-56 PMID: 14683734
  21. False positives in imaging genetics.
    Neuroimage. 2008 Apr 1;40(2):655-661 PMID: 18201908
  22. Distributional assumptions in voxel-based morphometry.
    Neuroimage. 2002 Oct;17(2):1027-30 PMID: 12377176
  23. A fast diffeomorphic image registration algorithm.
    Neuroimage. 2007 Oct 15;38(1):95-113 PMID: 17761438
  24. A review of group ICA for fMRI data and ICA for joint inference of imaging, genetic, and ERP data.
    Neuroimage. 2009 Mar;45(1 Suppl):S163-72 PMID: 19059344
  25. Nonstationary cluster-size inference with random field and permutation methods.
    Neuroimage. 2004 Jun;22(2):676-87 PMID: 15193596
  26. False discovery rate revisited: FDR and topological inference using Gaussian random fields.
    Neuroimage. 2009 Jan 1;44(1):62-70 PMID: 18603449
  27. A unified statistical approach for determining significant signals in images of cerebral activation.
    Hum Brain Mapp. 1996;4(1):58-73 PMID: 20408186
  28. Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease.
    Neuroimage. 2009 Feb 1;44(3):724-8 PMID: 19013250
  29. Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivo.
    Neuroimage. 2009 May 1;45(4):1090-8 PMID: 19349226
  30. Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort.
    Neuroimage. 2010 Nov 15;53(3):1051-63 PMID: 20100581
  31. Non-normality and transformations of random fields, with an application to voxel-based morphometry.
    Neuroimage. 2007 Mar;35(1):121-30 PMID: 17222566
  32. Imaging genetics: perspectives from studies of genetically driven variation in serotonin function and corticolimbic affective processing.
    Biol Psychiatry. 2006 May 15;59(10):888-97 PMID: 16442081
  33. Combining spatial extent and peak intensity to test for activations in functional imaging.
    Neuroimage. 1997 Feb;5(2):83-96 PMID: 9345540
Article Info
Journal
NeuroImage
Abbr.
Neuroimage
ISSN
1095-9572
Published
2011-01-15
Epub
2010-00-20
Pages
992-1000
Language
English
Region
United States
NLM ID
9215515
PMCID
PMC3063336
Subset
IM
Grants
NIA NIH HHS · K01 AG030514 · United States
Wellcome Trust · United Kingdom
NIA NIH HHS · U24 AG021886 · United States
Medical Research Council · G0900908 · United Kingdom
NIA NIH HHS · P30 AG010129 · United States
NIA NIH HHS · U01 AG024904 · United States
NIA NIH HHS · U19 AG010483 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]